- $8.04bn
- $7.24bn
- $115.79m
- 36
- 13
- 53
- 26
Annual income statement for Astera Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG |
Status: | Final | Final |
Revenue | ||
Total Revenue | 79.9 | 116 |
Cost of Revenue | ||
Gross Profit | 58.7 | 79.8 |
Selling / General / Administrative Expenses | ||
Research And Development | ||
Total Operating Expenses | 140 | 145 |
Operating Profit | -60.2 | -29.5 |
Total Net Non Operating Interest Income / Expense | ||
Net Income Before Taxes | -57.6 | -22.9 |
Provision for Income Taxes | ||
Net Income After Taxes | -58.3 | -26.3 |
Net Income Before Extraordinary Items | ||
Net Income | -58.3 | -26.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -58.3 | -26.3 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -0.383 | -0.172 |
Dividends per Share |